✦ LIBER ✦

Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies

✍ Scribed by Richard A. Larson, Robert B. Geller, Linda Janisch…

Book ID: 120776383
Publisher: Springer
Year: 1995
Tongue: English
Weight: 673 KB
Volume: 36
Category: Article
ISSN: 0344-5704
DOI: 10.1007/BF00685847

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of dactinomycin intraven

A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies

✍ Martin S. Blumenreich; Thomas M. Woodcock; Stephen P. Richman; Mariesa K. Jones; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 3 views

Eighteen patients with advanced malignancies refractory to other forms of treatment were given dactinomycin (Act D) as continuous intravenous infusions. Their median age was 51 years (range, 36-67); their median performance status was 50 (range, 40-90) on the Karnofsky scale. Act D was administered

A phase I trial of gemcitabine plus clad

A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases

✍ Olatoyosi M. Odenike; Ronald M. Sobecks; Linda Janisch; Dezheng Huo; Todd M. Zim 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 202 KB

Amifostine pretreatment for protection a

Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignancies

✍ Michael A Gold; Joan L Walker; Jonathan S Berek; Alton V Hallum III; Dava J Garc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 75 KB

A Phase I Study of the Metal Ionophore C

A Phase I Study of the Metal Ionophore Clioquinol in Patients With Advanced Hematologic Malignancies

✍ Aaron D. Schimmer; Yulia Jitkova; Marcela Gronda; Zezhou Wang; Joseph Brandwein; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 367 KB

A phase I trial of cisplatin in hyperton

A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies

✍ Leonard Saltz; David Kelsen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 2 views

Spisulosine (ES-285) given as a weekly t

Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies

✍ P. Schöffski; H. Dumez; R. Ruijter; B. Miguel-Lillo; A. Soto-Matos; V. Alfaro; G 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 285 KB